Open access
Sep 2026
Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment
A rapid, proof-of-concept microfluidic assay for cancer biomarker quantification and functional therapy evaluation that requires only 5 µL of sample, eliminates tedious sample manipulation, and uses commercial antibodies to track both biomarker concentration and functional activity.
Shaked Doron, Lev Brio, Matan Krasner et al.
· Biosensors · 0 citations